167 related articles for article (PubMed ID: 34253580)
1. Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network.
Akturk G; Parra ER; Gjini E; Lako A; Lee JJ; Neuberg D; Zhang J; Yao S; Laface I; Rogic A; Chen PH; Sanchez-Espiridion B; Valle DMD; Moravec R; Kinders R; Hudgens C; Wu C; Wistuba II; Thurin M; Hewitt SM; Rodig S; Gnjatic S; Tetzlaff MT
Clin Cancer Res; 2021 Sep; 27(18):5072-5083. PubMed ID: 34253580
[TBL] [Abstract][Full Text] [Related]
2. Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC).
Chen HX; Song M; Maecker HT; Gnjatic S; Patton D; Lee JJ; Adam SJ; Moravec R; Liu XS; Cerami E; Lindsay J; Tang M; Hodi FS; Wu CJ; Wistuba II; Al-Atrash G; Bernatchez C; Bendall SC; Hewitt SM; Sharon E; Streicher H; Enos RA; Bowman MD; Tatard-Leitman VM; Sanchez-Espiridion B; Ranasinghe S; Pichavant M; Del Valle DM; Yu J; Janssens S; Peterson-Klaus J; Rowe C; Bongers G; Jenq RR; Chang CC; Abrams JS; Mooney M; Doroshow JH; Harris LN; Thurin M
Clin Cancer Res; 2021 Sep; 27(18):5038-5048. PubMed ID: 33419780
[TBL] [Abstract][Full Text] [Related]
3. Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.
Sahaf B; Pichavant M; Lee BH; Duault C; Thrash EM; Davila M; Fernandez N; Millerchip K; Bentebibel SE; Haymaker C; Sigal N; Del Valle DM; Ranasinghe S; Fayle S; Sanchez-Espiridion B; Zhang J; Bernatchez C; Wu CJ; Wistuba II; Kim-Schulze S; Gnjatic S; Bendall SC; Song M; Thurin M; Lee JJ; Maecker HT; Rahman A
Clin Cancer Res; 2021 Sep; 27(18):5062-5071. PubMed ID: 34266889
[TBL] [Abstract][Full Text] [Related]
4. Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.
Zeng Z; Fu J; Cibulskis C; Jhaveri A; Gumbs C; Das B; Sanchez-Espiridion B; Janssens S; Taing L; Wang J; Lindsay J; Vilimas T; Zhang J; Tokheim C; Sahu A; Jiang P; Yan C; Duose DY; Cerami E; Chen L; Cohen D; Chen Q; Enos R; Huang X; Lee JJ; Liu Y; Neuberg DS; Nguyen C; Patterson C; Sarkar S; Shukla S; Tang M; Tsuji J; Uduman M; Wang X; Weirather JL; Yu J; Yu J; Zhang J; Zhang J; Meerzaman D; Thurin M; Futreal A; Karlovich C; Gabriel SB; Wistuba II; Liu XS; Wu CJ
Clin Cancer Res; 2021 Sep; 27(18):5049-5061. PubMed ID: 33323402
[TBL] [Abstract][Full Text] [Related]
5. The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
Taube JM; Akturk G; Angelo M; Engle EL; Gnjatic S; Greenbaum S; Greenwald NF; Hedvat CV; Hollmann TJ; Juco J; Parra ER; Rebelatto MC; Rimm DL; Rodriguez-Canales J; Schalper KA; Stack EC; Ferreira CS; Korski K; Lako A; Rodig SJ; Schenck E; Steele KE; Surace MJ; Tetzlaff MT; von Loga K; Wistuba II; Bifulco CB;
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414858
[TBL] [Abstract][Full Text] [Related]
6. Multiplex immunofluorescence staining and image analysis assay for diffuse large B cell lymphoma.
Lee CW; Ren YJ; Marella M; Wang M; Hartke J; Couto SS
J Immunol Methods; 2020 Mar; 478():112714. PubMed ID: 31783023
[TBL] [Abstract][Full Text] [Related]
7. Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study.
Taube JM; Roman K; Engle EL; Wang C; Ballesteros-Merino C; Jensen SM; McGuire J; Jiang M; Coltharp C; Remeniuk B; Wistuba I; Locke D; Parra ER; Fox BA; Rimm DL; Hoyt C
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266881
[TBL] [Abstract][Full Text] [Related]
8. Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists.
Harms PW; Frankel TL; Moutafi M; Rao A; Rimm DL; Taube JM; Thomas D; Chan MP; Pantanowitz L
Mod Pathol; 2023 Jul; 36(7):100197. PubMed ID: 37105494
[TBL] [Abstract][Full Text] [Related]
9. Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis.
Akturk G; Sweeney R; Remark R; Merad M; Gnjatic S
Methods Mol Biol; 2020; 2055():497-519. PubMed ID: 31502167
[TBL] [Abstract][Full Text] [Related]
10. Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system.
Laurinaviciene A; Plancoulaine B; Baltrusaityte I; Meskauskas R; Besusparis J; Lesciute-Krilaviciene D; Raudeliunas D; Iqbal Y; Herlin P; Laurinavicius A
Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S10. PubMed ID: 25565007
[TBL] [Abstract][Full Text] [Related]
11. Multiplex Immunofluorescence Assays.
Francisco-Cruz A; Parra ER; Tetzlaff MT; Wistuba II
Methods Mol Biol; 2020; 2055():467-495. PubMed ID: 31502166
[TBL] [Abstract][Full Text] [Related]
12. UltraPlex Hapten-Based Multiplexed Fluorescent Immunohistochemistry.
Levin M; Flor AC; Snyder H; Kron SJ; Schwartz D
Methods Mol Biol; 2021; 2350():267-287. PubMed ID: 34331291
[TBL] [Abstract][Full Text] [Related]
13. Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging.
Du Z; Lin JR; Rashid R; Maliga Z; Wang S; Aster JC; Izar B; Sorger PK; Santagata S
Nat Protoc; 2019 Oct; 14(10):2900-2930. PubMed ID: 31534232
[TBL] [Abstract][Full Text] [Related]
14. Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.
Sanchez K; Kim I; Chun B; Pucilowska J; Redmond WL; Urba WJ; Martel M; Wu Y; Campbell M; Sun Z; Grunkemeier G; Chang SC; Bernard B; Page DB
Breast Cancer Res; 2021 Jan; 23(1):2. PubMed ID: 33413574
[TBL] [Abstract][Full Text] [Related]
15. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
[TBL] [Abstract][Full Text] [Related]
16. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring.
Rizzardi AE; Johnson AT; Vogel RI; Pambuccian SE; Henriksen J; Skubitz AP; Metzger GJ; Schmechel SC
Diagn Pathol; 2012 Jun; 7():42. PubMed ID: 22515559
[TBL] [Abstract][Full Text] [Related]
17. Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma.
Xie Y; Olkhov-Mitsel E; Alminawi S; Slodkowska E; Downes MR
Pathol Res Pract; 2021 Oct; 226():153607. PubMed ID: 34509050
[TBL] [Abstract][Full Text] [Related]
18. Overview of Tissue Imaging Methods.
Patel SS; Rodig SJ
Methods Mol Biol; 2020; 2055():455-465. PubMed ID: 31502165
[TBL] [Abstract][Full Text] [Related]
19. Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.
Parra ER; Zhai J; Tamegnon A; Zhou N; Pandurengan RK; Barreto C; Jiang M; Rice DC; Creasy C; Vaporciyan AA; Hofstetter WL; Tsao AS; Wistuba II; Sepesi B; Haymaker C
Sci Rep; 2021 Feb; 11(1):4530. PubMed ID: 33633208
[TBL] [Abstract][Full Text] [Related]
20. Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients.
Mezheyeuski A; Bergsland CH; Backman M; Djureinovic D; Sjöblom T; Bruun J; Micke P
J Pathol; 2018 Apr; 244(4):421-431. PubMed ID: 29282718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
